Wavemaker Three-Sixty Health LP is a Los Angeles-based, early-stage (Seed/Series A) health technology-focused fund investing across the United States founded in 2018.
They look for dominant businesses which are focused on early-stage seed, health technology investments.
The Fund invests in early-stage seed franchises focusing on health technology investments.
What I found most interesting was Frank Stonebanks's presentation of the health technology innovation:
- Collective health tech target markets (i.e. HealthTech, DX/Tools, Devices) showed bigger than all biopharma
- 2019-2020 showed the biggest year-over-year growth in fundraising (57%) since 2011.
- The number of life science-only funds in 2020 versus 2019 were the same (28) but median deal size was ~2x higher ($415M vs $217M)